                         SEQUENCE LISTING

<110>  UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
       XIE, JIN
       KUMAR, ANIL
 
<120>  FUNCTIONALLY MODIFIED MAYTANSINOIDS AND COMPOSITIONS AND METHODS 
       OF USE THEREOF

<130>  UGA 2020-078 PCT

<150>  62/931,058
<151>  2019-11-05

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)
<223>  X = any amino acid

<220>
<221>  MISC_FEATURE
<222>  (8)..(9)
<223>  X = any amino acid

<400>  1

Xaa Xaa Cys Asn Gly Arg Cys Xaa Xaa 
1               5                   


<210>  2
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  X= any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X= cysteine or any amino acid (C/X)

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X= cysteine or any amino acid (C/X)

<220>
<221>  MISC_FEATURE
<222>  (9)..(10)
<223>  X= any amino acid

<400>  2

Cys Xaa Xaa Xaa Asn Gly Arg Xaa Xaa Xaa Cys 
1               5                   10      


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(11)
<223>  X= any amino acid

<400>  3

Cys Asn Gly Arg Cys Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10      


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  4

Cys Arg Gly Arg Arg Ser Thr 
1               5           


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  5

Gln Leu Tyr Glu Asn Lys Pro Arg Arg Pro Tyr Ile Leu 
1               5                   10              


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  6

Pro Arg Arg Pro Tyr Ile Leu 
1               5           


